Niko Bausch

Identifying, evaluating and executing on potential licensing and M&A opportunities in the Healthcare and Diagnostic industry. Identification of potential M&A targets in collaboration with corporate business development. Responsibility for negations and contracts with external business partners and for value creating license and patent agreements. Identification of new diagnostic markers according to the strategic direction. Networking with internal and external opinion leaders and business partners.

Support of entrepreneurs and early stage company development. Evaluate academic inventions of the University of Freiburg, with special focus on medical technologies, life sciences and renewable energy projects. Develope business models and translate them into successful startup companies. Technology Management to commercialize IP via licensing, spin-off and start-up company creation. Generate financial support from public and/or private funding programs and investment partners.

Responsible for marketing the software product “Selector” (genome comparisons using NGS and related omics data). Market and competitor analyses, identification of new markets, segmentation, positioning, new market entry campaigns, communications (press release / web site/ videos).

- Responsible for business development and project management in a preclinical CRO working in the area of oncology. - Negotiation of contracts (CDA, MSA, collaboration/licences/FTE agreements) for the acquisition of oncology research projects. Project management (consulting and project handling, member of steering committees), budget tracking of contracts and grants (BMBF, EU projects). Configuration of an Access database for project-, budget- and invoice tracking. - Product and market development esp.

ð Installation and commission of a proteomics laboratory in a biotechnological company. Responsible for the protein analysis (by 2D electrophoresis) for customers and internal research projects. Project management of research contracts.

Participation in the creation of Metabolic Explorer. Preparation of the feasibility study (market analysis, business plan, …). Technological transfer of the 2D electrophoresis from a public laboratory in Lyon to Metabolic Explorer.

Marketing and Sales of Genolife services (detection of GMOs in crops and processed foods) in Germany.

Elective courses in “M&A”, “Financial Risk Management”. Compulsory courses in Finance, Economics, Marketing, Accounting, Strategic Planning, Organisational Behaviour.

Biochemistry, Genetic